AndersonBM, Schnetz-BoutaudN, BartlettJ, et al.Examination of association to autism of common genetic variation in genes related to dopamine. Autism Res, 2008; 1(6):364–369.
2.
BaumanML, KemperTL. The Neurobiology of Autism. Johns Hopkins University Press: Baltimore, MD, USA; 2006.
3.
ChernoffCS, HynesTJ, WinstanleyCA. Noradrenergic contributions to cue-driven risk-taking and impulsivity. Psychopharmacology, 2021; 238(7):1765–1779.
4.
ConnorDF, BarkleyRA, DavisHT. A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clin Pediatr, 2000; 39(1):15–25.
5.
DalleyJW, RoiserJP. Dopamine, serotonin and impulsivity. Neuroscience, 2012; 215:42–58.
6.
DeutschSI, UrbanoMR, NeumannSA, et al.Cholinergic abnormalities in autism. Clin Neuropharmacol, 2010; 33(3):114–120.
7.
FernandezTV, SandersSJ, YurkiewiczIR, et al.Rare copy number variants in Tourette syndrome disrupt genes in histaminergic pathways and overlap with autism. Biol Psychiatry, 2012; 71(5):392–402.
8.
KollinsSH, JainR, BramsM, et al.(2011) Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD. Pediatrics, 2011; 127(6):e1406-13.
9.
LimS, LeeS. Chemical modulators for targeting autism spectrum disorders: From bench to clinic. Molecules, 2022; 27(16):5088.
10.
MingX, GordonE, KangN, et al.Use of clonidine in children with autism spectrum disorders. Brain Dev, 2008; 30(7):454–460.
11.
MrugS, ElliottMN, DaviesS, et al.Early puberty, negative peer influence, and problem behaviors in adolescent girls. Pediatrics, 2014; 133(1):7–14.
12.
ParikhMS, KolevzonA, HollanderE. Psychopharmacology of aggression in children and adolescents with autism: A critical review of efficacy and tolerability. J Child Adolesc Psychopharmacol, 2008; 18(2):157–178.
13.
PerryEK, LeeML, Martin-RuizCM, et al.Cholinergic activity in autism: Abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry, 2001; 158(7):1058–1066.
14.
SeoD, PatrickCJ, KennealyPJ. Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggress Violent Behav, 2008; 13(5):383–395.
15.
ShihJJ, LeslieMazwiT, FalcaoG, et al.Directed aggressive behavior in frontal lobe epilepsy: A video-EEG and ICTAL SPECT case study. Neurology, 2009; 73(21):1804–1806.
16.
SupekarK, KochalkaJ, SchaerM, et al.Deficits in mesolimbic reward pathway underlie social interaction impairments in children with autism. Brain, 2018; 141(9):2795–2805.
17.
U.S. Food and Drug Administration. Be aware of potentially dangerous products and therapies. 2019. Available at: https://www.fda.gov/consumers/consumer-updates/be-aware-potentially-dangerous-products-and-therapies-claim-treat-autism [Last accessed: June8, 2023].
18.
WilensTE, SpencerT, BiedermanJ, et al.Combined pharmacotherapy: An emerging trend in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry, 1995; 34(1):110–112.
19.
WilliamsK, BrignellA, RandallM, et al.Selective serotonin reuptake inhibitors (ssris) for autism spectrum disorders (ASD). Cochrane Database Syst Rev, 2013;(8):CD004677.
20.
WrightC, ShinJH, RajpurohitA, et al.Altered expression of histamine signaling genes in autism spectrum disorder. Transl Psychiatry, 2017; 7(5):e1126.
